Kerba, Marc

Radiation Oncology

Clinical Associate Professor

Biography

Dr. Kerba is a GI, lung and palliative radiation oncologist at the Tom Baker Cancer Centre and a clinical associate professor in the Department of Oncology at the University of Calgary, Cumming School of Medicine. He completed his medical training at the University of Toronto and radiation oncology residency at McMaster University. Dr. Kerba was awarded a CIHR sponsored fellowship in health services research at Queen’s University, Cancer Research Institute, and obtained a Master’s of Public Administration in health policy.

He is currently involved in several committees; as a Royal College examiner in radiation oncology, as Alberta’s representative on the Canadian Partnership Against Cancer System Performance Steering Committee, a member of the Canadian Cancer Trials Group Economics and Symptom Control Committees, a GI panel advisor to the pan-Canadian Oncology Drug Review/Canadian Agency for Drugs and Technologies in Health, and works with the American Society of Clinical Oncology Quality of Care and Measures Task Force Committees.

Area of Focus

  • Health Services Research, Clinical Trials

Summary of Research

Summary of Research

Dr. Marc Kerba’s research interests include health services research in the provision of cancer services, clinical trials both at the local and national level. He is currently involved in several research initiatives aimed at improving care for our patients with advanced cancer.

Sample publications

  • Martell K, Fairchild A,  LeGerrier B, Sinha R, Baker S, Liu H , Ghose A , Olivotto I,  Kerba M, “Rates of cannabis use in patients with cancer” Current Oncology. 2018; 25(3): 219-225
  • Shack L, Lu S, Craighead P, Kerba M “Determining the Need and Utilization for Radiotherapy in Cancers of The Breast, Cervix, Lung, Prostate and Rectum In Alberta Canada: A population level study” Radiother Oncol 2017;122(1):152-158.
  • Liu H, Gabos M, Ghosh S, Liu H, Lau H, Roberts B, Kerba M. “Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada” Radiother Oncol 2015;117(1):71-6
  • Koo K, Kerba M, Zeng L, Chow E, Sahgal A, “Quality of Life in Patients with Brain Metastases Receiving Upfront as Compared to Salvage Stereotactic Radiosurgery Using the EORTC QLQ-C15-PAL and the EORTC QLQ BN20+2: A Pilot Study” J Radiat Oncol 2013;2:217-224, ISSN:1948-789, 4DOI 10.1007/s13566-012-0052-9
  • Kerba M, Wu J, Duan Q, Hagen N, Bennett M. “Prevalence of Neuropathic Pain Symptoms in Patients Receiving Palliative Radiotherapy For Bone Metastases.” J Clin Oncol 2010;28(33): 4892-97

Area Of Focus

  • Health Services Research, Clinical Trials

Summary Of Research

Summary of Research

Dr. Marc Kerba’s research interests include health services research in the provision of cancer services, clinical trials both at the local and national level. He is currently involved in several research initiatives aimed at improving care for our patients with advanced cancer.

Sample publications

  • Martell K, Fairchild A,  LeGerrier B, Sinha R, Baker S, Liu H , Ghose A , Olivotto I,  Kerba M, “Rates of cannabis use in patients with cancer” Current Oncology. 2018; 25(3): 219-225
  • Shack L, Lu S, Craighead P, Kerba M “Determining the Need and Utilization for Radiotherapy in Cancers of The Breast, Cervix, Lung, Prostate and Rectum In Alberta Canada: A population level study” Radiother Oncol 2017;122(1):152-158.
  • Liu H, Gabos M, Ghosh S, Liu H, Lau H, Roberts B, Kerba M. “Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta, Canada” Radiother Oncol 2015;117(1):71-6
  • Koo K, Kerba M, Zeng L, Chow E, Sahgal A, “Quality of Life in Patients with Brain Metastases Receiving Upfront as Compared to Salvage Stereotactic Radiosurgery Using the EORTC QLQ-C15-PAL and the EORTC QLQ BN20+2: A Pilot Study” J Radiat Oncol 2013;2:217-224, ISSN:1948-789, 4DOI 10.1007/s13566-012-0052-9
  • Kerba M, Wu J, Duan Q, Hagen N, Bennett M. “Prevalence of Neuropathic Pain Symptoms in Patients Receiving Palliative Radiotherapy For Bone Metastases.” J Clin Oncol 2010;28(33): 4892-97